PLRZ:Polyrizon Ltd Snapshot | Charting | News | Options
$12.61 NASDAQ 8:15a ET
December 11 '25 		Polyrizon Announces Promising Permeation Kinetics Supporting Advancement of Its Intranasal Naloxone Hydrog... GlobeNewswire
Last  Change Exchange
Market data is delayed by at least 15 minutes.
Markets Portfolio
    Symbol Lookup
    Latest Story
    Polyrizon Announces Promising Permeation Kinetics Supporting Advancement of Its Intranasal Naloxone Hydrogel Program
     GlobeNewswire
    Full Story →

    Headline News
    Polyrizon Completes FDA Pre-Submission Meeting for PL-14 Allergy Blocker Nasal Spray
    8:54a ET December 8 '25 GlobeNewswire
    From Lab to Global Impact: Polyrizon's Journey to Potentially Redefining Next-Generation Nasal Protection
    7:31a ET December 4 '25 GlobeNewswire
    Polyrizon Reports Positive Mucoadhesion Results for Intranasal Naloxone Hydrogel Compared to Marketed Intranasal Naloxone product
    9:27a ET December 3 '25 GlobeNewswire
    More News →
    Day  1.65%Week  3.74%Month  176%More Charting →
    December 12 '25. Markets Closed.
    Last $12.61
    Day change   1.65%$0.21
    Open $12.45
    Gap at open $0.04
    Previous close $12.41
    Trading volume 338,730
    10 Day avg vol. 19,055,679
    Shares out. 1.0Mil
    Market cap. $13.1Mil
    Trading activity Below Avg.
    Previous data from yesterday, December 11 '25.

    Historical Price Performance
    3 month   78.11% 
    6 month   163% 
    1 year   99.15% 
    2 year   NA 
    NA = Not Available

    Earnings
    Previous 12m -$582.43
    Next 12m Estimate NM
    P/E ratio --
    Revenue 0Mil

    Market data provided by News provided by


    This site is published in the United States for U.S. residents only. The services offered within this site are available exclusively through our U.S. Financial Advisors. Stifel Nicolaus Financial Advisors may only conduct business with residents of the state in which they are properly registered. The information on this website is not an offer to sell or a solicitation of an offer to buy, any security, nor shall any such security be offered or sold to any person in any jurisdiction in which such offer, solicitation, purchase or sale may not lawfully be made.
    Important Disclosures | Privacy Notice | HIPAA Policy | Use of Information Policy | Business Continuity | Canada Trade Matching Statement

    Stifel, Nicolaus & Co., Inc. Member NYSE, FINRA, and SIPC.
    Stifel Nicolaus Canada Inc., is a member of CIPF/FCPE and IIROC
    Copyright © 2025 All rights reserved.